Nectar Lifesciences informs about statements of investor complaints

04 Jan 2018 Evaluate

Pursuant to Regulation 13(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed about the Statement of Investor Complaints for the Quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

 

Nectar Lifesciences Share Price

18.58 -0.56 (-2.93%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×